Johns Hopkins Kimmel Cancer Center

FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation

The FDA has approved a new drug treatment for a type of brain cancer called low-grade glioma. The drug, called vorasidenib, is a targeted cancer… Read More »FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation

In this Cancer Matters podcast, Dr Bill Nelson speaks with Robin Hopkins, the author of What Happens Now?, and Dr Tom Smith about how we… Read More »Cancer Matters with Dr Bill Nelson – What Happens Now?

The Harry J Duffey Family Patient and Family Services Program at the Johns Hopkins Kimmel Cancer Center has compiled a list of events, activities, and… Read More »Living with Cancer Resources and Support – August 2024

In this On Target podcast, Dr Akila Viswanathan speaks with Dr Charles Thomas from the Dartmouth Cancer Center and Dr Ethan Ludmir from the MD… Read More »On Target with Dr Akila Viswanathan – Clinical Trials for Seminars in Radiation Oncology

In this On Target podcast, Dr Akila Viswanathan talks with Dr Daniel Low, Vice Chair of Medical Physics Research and Innovation at UCLA Health, about… Read More »On Target with Dr Akila Viswanathan – MR Guided Radiation Therapy for Seminars in Radiation Oncology

In this On Target podcast, Dr Akila Viswanathan talks to Dr David Kirsch from the Princess Margaret Cancer Centre/University Health Network about treating soft tissue… Read More »On Target with Dr. Akila Viswanathan – The Science and Management of Soft Tissue Sarcomas for Seminars in Radiation Oncology

In this Cancer Matters podcast, Dr Bill Nelson talks to Dr Ken Kinzler, cancer researcher and Co-Director of Ludwig Cancer Research at Johns Hopkins, about… Read More »Cancer Matters with Dr. Bill Nelson – Cancer Genetics

In this Cancer Matters podcast, Dr Bill Nelson talks to Terri Conneran, the founder of KRAS Kickers, about the discovery of biomarkers, targeted treatments and… Read More »Cancer Matters with Dr. Bill Nelson – KRAS Kickers